Pulmonary hypertension in patients with chronic obstructive pulmonary disease: Recent advances in pathophysiology and management

Respirology

Volumn 7, Issue 1, 2002, Pages 3-13

  Hida, Wataru ^a,b   Tun, Ye ^c   Kikuchi, Yoshihiro ^c   Shirato, Kunio ^c  

^a Health Administration Center   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Cor pulmonale; Hypoxic pulmonary vasoconstriction; Long term oxygen therapy; Non invasive positive pressure ventilation; Pulmonary hypertension; Smoking cessation; Vascular remodelling

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COR PULMONALE; DISEASE COURSE; HUMAN; HYPOXIA; OXYGEN THERAPY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SMOKING CESSATION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANOXEMIA; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0036331883     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2002.00366.x     Document Type: Review

References (103)

1. The impact of COPD on lung health worldwide: Epidemiology and incidence
2. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
3. BTS guidelines for the management of chronic obstructive pulmonary disease
4. Course and prognosis of chronic obstructive lung disease: A prospective study of 200 patients
5. Prognosis in chronic obstructive pulmonary disease
6. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease
7. Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy
8. Prognostic factors in COPD patients receiving long-term oxygen therapy: Importance of pulmonary artery pressure
9. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease
10. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
11. Endothelin-1 in the lungs of patients with pulmonary hypertension
12. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia
13. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease
14. Pulmonary artery remodeling modifies pulmonary hypertension during exercise in severe emphysema
15. Patterns of cardiovascular dysfunction in chronic obstructive lung disease
16. Arterial oxygenation and pulmonary hemodynamics in patients with chronic airways obstruction
17. Mechanisms of acute hypoxic and hyperoxic changes in pulmonary vascular reactivity
18. 2 interaction on hypoxic pulmonary vasoconstriction
19. A study of the mechanisms involved in the pulmonary arterial pressor response to hypoxia
20. Potassium channels modulate hypoxic pulmonary vasoconstriction
21. + channels of hypoxic human pulmonary vascular cells
22. A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD
23. Potential role of arachidonic acid metabolites in hypoxic pulmonary vasoconstriction
24. Sites of pulmonary vasomotor reactivity in the dog during alveolar hypoxia and serotonin, and histamine infusion
25. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
26. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease
27. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease
28. Endothelial dysfunction in pulmonary arteries of patients with COPD
29. The role of endothelium in the hypoxic contraction of isolated human pulmonary artery
30. NO in the lung
31. Role of calpain in hypoxic inhibition of nitric oxide synthase activity in pulmonary endothelial cells
32. Nitric oxide and endothelin-1 in pulmonary hypertension
33. Nitric oxide and the proliferation of vascular smooth cells
34. A pathophysiological study of 10 cases of hypoxic cor pulmonale
35. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease
36. ET-1 modulates KCa-channel activity and arterial tension in normoxic and hypoxic human pulmonary vasculature
37. ATP channel
38. Regulation of endothelin-1 at rest and during a short steady-state exercise in 21 COPD patients
39. Adenosine plasma concentration in pulmonary hypertension
40. The pulmonary circulation in chronic bronchitis and emphysema
41. Morphological changes in the muscular arteries: Relationship to cigarette smoking, airway disease and emphysema
42. Pulmonary hemodynamics and physical training in patients with chronic obstructive pulmonary disease
43. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
44. Pulmonary hemodynamics, gas exchange, and the severity of emphysema as assessed by quantitative CT scan in chronic bronchitis and emphysema
45. 2 above 60 mmHg
46. 2 < 90%) in normoxic and mildly hypoxic patients with COPD
47. Breathing during sleep in patients with nocturnal desaturation
48. Association of chronic obstructive pulmonary disease and sleep apnea syndrome
49. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease
50. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen
51. 2 above 60 mmHg
52. Emphysema, hypoxia and the polycythemic response
53. Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease
54. Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction. Hematocrit dependence and the importance of nitric oxide
55. Effects of the RBC membrane and increased perfusate viscosity on hypoxic pulmonary vasoconstriction
56. The influence of the airways resistance and alveolar pressure on the pulmonary vascular resistance in chronic bronchitis
57. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease
58. Chronic cor pulmonale. Etiology and management
59. Pulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysis
60. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part one
61. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease
62. P wave height during incremental exercise in patients with chronic airway obstruction
63. Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management
64. Non-invasive estimation of pulmonary arterial hypertension in chronic obstructive pulmonary disease
65. Pulmonary artery hypertension in chronic obstructive pulmonary disease: Determination by chest radiography
66. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease
67. Two-dimensional echocardiographic assessment of the right ventricle in patients with chronic obstructive lung disease
68. Central pulmonary artery lesions in chronic obstructive pulmonary disease. A transoesophageal echocardiography study
69. Noninvasive prediction of pulmonary hypertension in chronic obstructive pulmonary disease by Doppler echocardiography
70. Pulsed Doppler echocardiography in the diagnosis of pulmonary hypertension in COPD
71. Non-invasive method to assess cor pulmonale in patients with chronic obstructive pulmonary disease
72. Detection of right ventricular pressure overloading by thallium-201 myocardial scintigraphy: Results in 57 patients with chronic respiratory diseases
73. Evaluation of cor pulmonale on a modified short-axis section of the heart by magnetic resonance imaging
74. Cardiac evaluation
75. Review of the clinical efficacy of theophylline in the treatment of chronic obstructive pulmonary disease
76. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
77. Randomized, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
78. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema
79. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease
80. Effects of long term oxygen therapy on pulmonary hemodynamics in COPD patients. A 6-year prospective study
81. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease
82. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia
83. Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy
84. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
85. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease
86. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease
87. Use of nitric oxide inhalation in chronic obstructive pulmonary disease
88. Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil
89. Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease
90. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
91. A placebo- controlled trial of prostacyclin in acute respiratory failure in COPD
92. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in hypoxaemic cor pulmonale
93. Pulmonary vascular pressures of thoroughbred horses exercised 1, 2, 3 and 4 h after furosemide administration
94. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study
95. Prognostic factors in medically treated patients with chronic pulmonary embolism
96. Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: Effects on pulmonary hemodynamics, gas exchange, and exercise capacity
97. Rationale for the use of non-invasive ventilation in chronic ventilatory failure
98. Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease
99. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease
100. Development of pulmonary hypertension after lung volume reduction surgery
101. Effects of lung volume reduction surgery on gas exchange and pulmonary hemodynamics at rest and during exercise
102. Effects of lung volume reduction surgery on exercise pulmonary hemodynamics in severe emphysema
103. Effect of lung volume reduction surgery on pulmonary hemodynamics in severe pulmonary emphysema